Invuity® Announces PhotonBlade™ Dynamic Precision Illuminator With Enhanced Energy
April 27 2017 - 7:20PM
Invuity, Inc. (NASDAQ:IVTY), an advanced surgical illumination
company focused on minimal access surgery, today at the
18th American Society of Breast Surgeons annual
scientific conference, announced the introduction of PhotonBlade™,
a dynamic precision illuminator with enhanced energy delivery.
PhotonBlade represents an entirely new category of Intelligent
Photonics®, delivering directed, thermally cool illumination at the
precise point of surgical treatment. Further, PhotonBlade’s novel
energy platform consists of a proprietary shielded blade for
precise cutting and coagulation of tissue, with minimal collateral
effect. This sophisticated illumination technology further allows
for unique use in a fluid filled environment and does not require a
proprietary generator, thereby leveraging widely available
operating room equipment and avoiding an institutional capital
investment.
"We are very proud and excited with the introduction of
PhotonBlade,” stated Philip Sawyer, President and CEO of Invuity.
“We collaborated with some of the top surgeons in the country on
its unique design, which was created for more visualization and
precision of the surgical field. This continues our strategic
intention to create entirely new categories of intelligent
photonics. The advanced illumination coupled with state-of-the-art
energy delivery positions us solidly in an initially estimated $300
million available market for this technology,” continued Sawyer.
“This demonstrates Invuity’s commitment to improving surgical
treatment options and positively impacting patient lives.”
Dr. Rache Simmons, Chief of Breast Surgery at New York
Presbyterian Weill Cornell Medical Center said, “The high-quality,
point-of-treatment illumination of PhotonBlade coupled with precise
energy delivery provides me with the optimal tool I need to perform
oncologically effective procedures through small, remote incisions.
Specifically, the intracavity illumination enables me to precisely
tunnel deep within a breast cavity to remove some or all of the
breast tissue from an incision that can be hidden. Ultimately, this
contributes to improved survivorship for my patients, which after
removing the cancer, is my number one priority.”
About Invuity®Invuity, Inc. is a leading medical technology
company focused on developing and marketing advanced surgical
devices to improve the ability of physicians to perform minimal
access surgery through smaller and hidden incisions. The company's
proprietary Intelligent Photonics™ technology delivers enhanced
visualization which facilitates surgical precision, efficiency and
safety. In addition, the company utilizes comprehensive strategic
marketing programs to create stronger institutional partnerships.
Clinical applications include women’s health, encompassing breast
cancer and breast reconstruction surgery, gynecology and thyroid
surgery. Additional applications include procedures for
electrophysiology, spine, orthopedic, cardiothoracic, and general
surgery. Invuity is headquartered in San Francisco, CA. For more
information, visit www.invuity.com.
Forward-Looking StatementsThis announcement contains
forward-looking statements that involve risks and uncertainties,
including statements regarding financial projections for 2017,
future product introductions, future sales and marketing
initiatives, and market opportunities. Actual results could differ
materially from those projected in the forward-looking statements
as a result of certain risk factors, including, but not limited to:
fluctuations in demand or failure to gain market acceptance for the
Company's devices; the Company's ability to demonstrate to and gain
approval from hospitals to use the Company's devices; the highly
competitive business environment for surgical medical devices; the
Company's ability to sell its devices at prices that support its
current business strategies; difficulty forecasting future
financial performance; protection of the Company's intellectual
property; and compliance with necessary regulatory clearances or
approvals. The Company undertakes no obligation to update the
forward-looking information in this release. More information about
potential factors that could affect the Company's business and
financial results is included in its filings with the Securities
and Exchange Commission, including, without limitation, under the
captions: "Management's Discussion and Analysis of Financial
Condition and Results of Operations," and "Risk Factors," which are
on file with the Securities and Exchange Commission.
CONTACTS:
Company Contact:
Joe Guido
Vice President
Commercial Marketing & Business Development
Invuity, Inc.
415-655-2103
Investors & Media:
Mark Klausner
Westwicke Partners
443-213-0501
irdept@invuity.com
INVUITY, INC. (NASDAQ:IVTY)
Historical Stock Chart
From Jun 2024 to Jul 2024
INVUITY, INC. (NASDAQ:IVTY)
Historical Stock Chart
From Jul 2023 to Jul 2024